These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12571627)

  • 1. Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
    Gupta VK; Park JO; Kurihara T; Koons A; Mauceri HJ; Jaskowiak NT; Kufe DW; Weichselbaum RR; Posner MC
    Gene Ther; 2003 Feb; 10(3):206-12. PubMed ID: 12571627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
    Kurihara T; Brough DE; Kovesdi I; Kufe DW
    J Clin Invest; 2000 Sep; 106(6):763-71. PubMed ID: 10995787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
    Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
    Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased injection number enhances adenoviral genetic radiotherapy.
    Mauceri HJ; Seung LP; Grdina WL; Swedberg KA; Weichselbaum RR
    Radiat Oncol Investig; 1997; 5(5):220-6. PubMed ID: 9372544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
    Block A; Milasinovic D; Mueller J; Schaefer P; Schaefer H; Greten H
    Anticancer Res; 2002; 22(6A):3285-92. PubMed ID: 12530077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
    Tai YT; Strobel T; Kufe D; Cannistra SA
    Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
    Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary adenoviral vectors for oncolysis.
    Alemany R; Lai S; Lou YC; Jan HY; Fang X; Zhang WW
    Cancer Gene Ther; 1999; 6(1):21-5. PubMed ID: 10078960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy.
    Thorne SH; Tam BY; Kirn DH; Contag CH; Kuo CJ
    Mol Ther; 2006 May; 13(5):938-46. PubMed ID: 16469543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
    Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
    Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.